The Human Medicines Regulations 2012

Signal detection: holder obligation

This section has no associated Explanatory Memorandum

190.—(1) The holder must inform the EMA and the licensing authority without delay if it detects any relevant changes in relation to the product.

(2) In this regulation, “relevant changes” has the meaning given in regulation 189(5).